Effectiveness and Safety of Apremilast in Immune Checkpoint Inhibitor‐Associated Psoriasis: A Retrospective Multicenter Study From the <scp>EADV</scp> Task Force “Dermatology for Cancer Patients”

Dimitra Koumaki, Ioannis‐Alexios Koumprentziotis, Zoe Apalla, Vincent Sibaud, Michela Valeria Rita Starace, Luca Rapparini, Sonia Segura, Gloria Juan‐Carpena, Mar Blanes‐Martínez, Chrysa Oikonomou, Florentina Delli, Elena Sotiriou, Ander Mayor, Joaquín López Robles, Monika Arenbergerová, Vasiliki Nikolaou

Open source

DOI: 10.1111/ijd.70592
Published: 2026-07-16
Container: International Journal of Dermatology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/ijd.70592,
  title = {Effectiveness and Safety of Apremilast in Immune Checkpoint Inhibitor‐Associated Psoriasis: A Retrospective Multicenter Study From the
                    <scp>EADV</scp>
                    Task Force “Dermatology for Cancer Patients”},
  author = {Dimitra Koumaki and Ioannis‐Alexios Koumprentziotis and Zoe Apalla and Vincent Sibaud and Michela Valeria Rita Starace and Luca Rapparini and Sonia Segura and Gloria Juan‐Carpena and Mar Blanes‐Martínez and Chrysa Oikonomou and Florentina Delli and Elena Sotiriou and Ander Mayor and Joaquín López Robles and Monika Arenbergerová and Vasiliki Nikolaou},
  year = {2026},
  journal = {International Journal of Dermatology},
  doi = {10.1111/ijd.70592},
  url = {https://doi.org/10.1111/ijd.70592}
}

RIS

TY  - JOUR
TI  - Effectiveness and Safety of Apremilast in Immune Checkpoint Inhibitor‐Associated Psoriasis: A Retrospective Multicenter Study From the
                    <scp>EADV</scp>
                    Task Force “Dermatology for Cancer Patients”
AU  - Dimitra Koumaki
AU  - Ioannis‐Alexios Koumprentziotis
AU  - Zoe Apalla
AU  - Vincent Sibaud
AU  - Michela Valeria Rita Starace
AU  - Luca Rapparini
AU  - Sonia Segura
AU  - Gloria Juan‐Carpena
AU  - Mar Blanes‐Martínez
AU  - Chrysa Oikonomou
AU  - Florentina Delli
AU  - Elena Sotiriou
AU  - Ander Mayor
AU  - Joaquín López Robles
AU  - Monika Arenbergerová
AU  - Vasiliki Nikolaou
PY  - 2026
JO  - International Journal of Dermatology
DO  - 10.1111/ijd.70592
UR  - https://doi.org/10.1111/ijd.70592
ER  -

APA

Koumaki, D., Koumprentziotis, I., Apalla, Z., Sibaud, V., Starace, M. V. R., Rapparini, L., Segura, S., Juan‐Carpena, G., Blanes‐Martínez, M., Oikonomou, C., Delli, F., Sotiriou, E., Mayor, A., Robles, J. L., Arenbergerová, M., & Nikolaou, V. (2026). Effectiveness and Safety of Apremilast in Immune Checkpoint Inhibitor‐Associated Psoriasis: A Retrospective Multicenter Study From the <scp>EADV</scp> Task Force “Dermatology for Cancer Patients”. International Journal of Dermatology. https://doi.org/10.1111/ijd.70592

Source records

crossref · retrieved 2026-09-27T09:06:06.801Z